NASDAQ:SINT

Sintx Technologies (SINT) Stock Price, News & Analysis

$0.04
0.00 (0.00%)
(As of 04/26/2024 ET)
Today's Range
$0.04
$0.04
50-Day Range
$0.02
$0.15
52-Week Range
$0.02
$1.82
Volume
24.58 million shs
Average Volume
76.88 million shs
Market Capitalization
$916,272.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SINT stock logo

About Sintx Technologies Stock (NASDAQ:SINT)

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

SINT Stock Price History

SINT Stock News Headlines

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Sintx Technologies Prices Public Offering Of $1.3 Mln Of Shares
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Why Is Sintx Technologies (SINT) Stock Down 31% Today?
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Sintx Technologies just downgraded at Maxim, here's why
Sintx Tech Announces Pricing Public Offering; Stock Down
See More Headlines
Receive SINT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sintx Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
4/28/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SINT
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

Net Income
$-8,260,000.00
Net Margins
-314.39%
Pretax Margin
-314.39%

Debt

Sales & Book Value

Annual Sales
$2.63 million
Book Value
$1.65 per share

Miscellaneous

Free Float
22,453,000
Market Cap
$916,272.00
Optionable
Not Optionable
Beta
1.46
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. B. Sonny Bal J.D. (Age 62)
    M.B.A., M.D., Ph.D., Chairman, President & CEO
    Comp: $460.81k
  • Mr. David Francis O'Brien (Age 58)
    Executive VP & COO
    Comp: $432.46k
  • Mr. Michael Marcroft
    Vice President of Sales & Marketing
  • Ms. Gina Moss
    Director of Operations

SINT Stock Analysis - Frequently Asked Questions

Should I buy or sell Sintx Technologies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sintx Technologies in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SINT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SINT, but not buy additional shares or sell existing shares.
View SINT analyst ratings
or view top-rated stocks.

How have SINT shares performed in 2024?

Sintx Technologies' stock was trading at $0.3814 on January 1st, 2024. Since then, SINT shares have decreased by 89.4% and is now trading at $0.0404.
View the best growth stocks for 2024 here
.

Are investors shorting Sintx Technologies?

Sintx Technologies saw a drop in short interest in April. As of April 15th, there was short interest totaling 554,400 shares, a drop of 54.6% from the March 31st total of 1,220,000 shares. Based on an average trading volume of 26,850,000 shares, the short-interest ratio is presently 0.0 days.
View Sintx Technologies' Short Interest
.

When is Sintx Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our SINT earnings forecast
.

How were Sintx Technologies' earnings last quarter?

Sintx Technologies, Inc. (NASDAQ:SINT) posted its quarterly earnings data on Wednesday, March, 27th. The company reported ($0.09) earnings per share for the quarter. The company earned $0.90 million during the quarter. Sintx Technologies had a negative net margin of 314.39% and a negative trailing twelve-month return on equity of 67.12%.

When did Sintx Technologies' stock split?

Shares of Sintx Technologies reverse split on Monday, December 19th 2022. The 1-100 reverse split was announced on Monday, December 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of Sintx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sintx Technologies investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Heat Biologics (HTBX), iBio (IBIO), T2 Biosystems (TTOO), AIM ImmunoTech (AIM), Aytu BioPharma (AYTU), Blink Charging (BLNK), Bionano Genomics (BNGO) and Nuwellis (CHFS).

How do I buy shares of Sintx Technologies?

Shares of SINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SINT) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners